Shelton, CT - September 25, 2013 (Investorideas.com biometrics/ defense stocks newswire) NXT-ID, Inc. (OTCQB:NXTD) a biometrics company focused on the growing mobile commerce market, today announced the appointment of Dr. Michael J. d'Almada-Remedios to its Board of Directors. Dr. Remedios joins the company as an independent director, advising in key areas of technology development.

Dr. Remedios lends more than twenty years of experience in executive, product, technology and operations leadership as CTO, CIO, and COO. He has held key management positions at major e-commerce and social consumer brands including eBay/Shopping.com, Expedia/Hotels.com, Travelocity/Lastminute.com, Kmart/BlueLight.com and Wells Fargo Bank.

Read more: Biometric Stock Alert: NXT-ID, Inc. (OTCQB:NXTD) Appoints New Director with CTO, CIO and COO...

Stocks with high dividend yields and buy ratings originally published at long-term-investments.blogspot.com. Today I would like to give you an update of the higher capitalized stocks with buy ratings by brokerage firms. I personally prefer stocks with lower yields and better growth perspectives because I don't need high yields to live-off.

Only 13 stocks fulfilled these two criteria but the most of the results have an extraordinary high debt. It's very risky to buy stocks with large amounts of debt because debt owners got money before share owners. If there should develop some trouble, the dividends must keep flat or needed to reduce.

Stocks from the basic material sector as well as telecoms are the dominating categories. But there are also some good names on the list like Williams Partners or Altria.

Read more: 13 High-Yield Large Capitalized Stocks With Buy Or Better Recommendation

 SAN DIEGO - September 24, 2013 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), announced today that Dr. Cicek Gercel-Taylor has been appointed Clinical Research Director of Exosome Sciences, Inc. (ESI), a wholly-owned diagnostic subsidiary of Aethlon Medical. In this role, Dr. Gercel-Taylor will direct and plan the execution of diagnostic clinical programs and interact with collaborative partners and regulatory authorities.

Aethlon Medical develops therapeutic devices to address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.

Read more: Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) Announces the Appointment of Dr....

 Point Roberts, WA, New York, NY - September 24, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues an exclusive Q&A with Jim Joyce, Chairman and CEO of Aethlon Medical, Inc. (OTCQB:AEMD). Mr. Joyce discusses the recent launch of its new Exosome Sciences, Inc. (ESI) and what that potentially represents to Aethlon and its shareholders.

Read more: Medical Technology Q&A with Chairman and CEO of Aethlon Medical (OTCQB: AEMD) Discussing Launch of...

 New York, NY - September 23, 2013 (www.investorideas.com newswire) Investorideas.com, an investor portal specializing in sector research including biometrics and mobile security stocks, issues an updated directory for biometrics stocks following Apple’s report of selling over 9 Million iPhones over the weekend that incorporate biometric technology.

The new biometric Touch ID fingerprint technology has resulted in a new wave of interest in biometric technology and related stocks within the sector. Shares of Precise Biometrics, Fingerprint Cards, ImageWare Systems and NXT-ID, Inc have all benefited from the new buzz created by Apple’s implementation.

Read more: Biometrics Stocks Take Center Stage As Apple (AAPL) iPhone Sales Soar